
Ask a doctor about a prescription for DAPERIN 5 mg FILM-COATED TABLETS
Patient Information: Summary of Product Characteristics
Daperin 5mg film-coated tablets EFG
Daperin 10mg film-coated tablets EFG
dapagliflozin
Read the entire summary of product characteristics carefully before starting to take this medication, as it contains important information for you.
Contents of the Summary of Product Characteristics
What is Daperin
Daperin contains the active substance dapagliflozin. It belongs to a group of medications called "sodium-glucose cotransporter 2 (SGLT2) inhibitors". They work by blocking the SGLT2 protein in the kidney. By blocking this protein, sugar in the blood (glucose), salt (sodium), and water are eliminated from the body through urine.
What is Daperin used for
This medication is used to treat:
What is type 2 diabetes and how does Daperin help?
What is heart failure and how does Daperin help?
What is chronic kidney disease and how does Daperin help?
Do not take Daperin
Warnings and precautions
Contact a doctor or the nearest hospital immediately
Diabetic ketoacidosis:
If you suspect you have diabetic ketoacidosis, contact a doctor or the nearest hospital immediately and do not take this medication.
Necrotizing fasciitis of the perineum:
Consult your doctor, pharmacist, or nurse before starting to take this medication
If any of the above situations apply to you (or you are unsure), consult your doctor, pharmacist, or nurse before taking dapagliflozin.
Diabetes and foot care
If you have diabetes, it is essential that you regularly check your feet and follow any other foot care advice provided by your healthcare professional.
Glucose in urine
Due to how dapagliflozin works, your urine will test positive for glucose while you are taking this medication.
Children and adolescents
Dapagliflozin can be used in children aged 10 years or older for the treatment of type 2 diabetes. There is no data available in children under 10 years of age.
This medication is not recommended in children or adolescents under 18 years of age for the treatment of heart failure or for the treatment of chronic kidney disease, as it has not been studied in these patients.
Other medications and Daperin
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medications.
Especially inform your doctor:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
You should stop taking this medication if you become pregnant, as its use is not recommended during the second and third trimesters of pregnancy. Consult your doctor about the best way to control blood sugar levels during pregnancy.
Consult your doctor if you want to breastfeed or are breastfeeding before taking this medication. Do not use dapagliflozin during breastfeeding. It is unknown whether this medication passes into human breast milk.
Driving and using machines
This medication has a negligible influence on the ability to drive or use machines.
Taking this medication with other medications called sulfonylureas or with insulin may cause low blood sugar levels (hypoglycemia), which can cause symptoms such as trembling, sweating, and vision disturbances that can affect your ability to drive or use machines.
Do not drive or use tools or machines if you feel dizzy while taking dapagliflozin.
Daperin contains lactose
Daperin contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medication.
Follow the instructions for administration of this medication exactly as indicated by your doctor. In case of doubt, consult your doctor, pharmacist, or nurse again.
What dose should you take
How to take this medication
Your doctor may prescribe dapagliflozin in combination with another medication(s). Remember to take these other medication(s) as instructed by your doctor. This will help you achieve the best results for your health.
Diet and exercise can help your body use blood sugar more effectively. If you have diabetes, it is essential that you follow any diet and exercise program recommended by your doctor while taking dapagliflozin.
If you take more Daperin than you should
If you take more dapagliflozin tablets than you should, consult your doctor or go to the hospital immediately. Bring the medication packaging with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Daperin
What you should do if you forget to take a tablet depends on how much time is left until your next dose.
If you stop taking Daperin
Do not stop taking dapagliflozin without consulting your doctor first. If you have diabetes, your blood sugar levels may increase without this medication.
If you have any further questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medications, this medication can cause side effects, although not everyone gets them.
Contact a doctor or the nearest hospital immediately if you experience any of the following side effects:
These are the signs of angioedema:
These are the signs of diabetic ketoacidosis (see also section 2 Warnings and precautions):
This can occur regardless of blood sugar levels. Your doctor should decide whether to temporarily or permanently stop your treatment with dapagliflozin.
Stop taking Daperin and consult a doctor immediately if you notice any of these serious side effects:
These are the signs of a severe urinary tract infection:
Although it is not very common, if you notice blood in your urine, inform your doctor immediately.
Contact your doctor as soon as possible if you experience any of the following side effects:
These are the signs of low blood sugar levels:
Your doctor will explain how to treat low blood sugar levels and what to do if you experience any of the above signs.
Other side effects of treatment with Daperin:
Common
Uncommon (may affect up to 1 in 100 people)
Rare
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this summary of product characteristics. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the blister or carton after "EXP". The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. In case of doubt, ask your pharmacist how to dispose of the packaging and any unused medication at the SIGRE point in the pharmacy. This will help protect the environment.
Daperin Composition
Each film-coated tablet (tablet) of Daperin 5 mg contains dapagliflozina propanediol monohydrate equivalent to 5 mg of dapagliflozin.
Each film-coated tablet (tablet) of Daperin 10 mg contains dapagliflozina propanediol monohydrate equivalent to 10 mg of dapagliflozin.
Product Appearance and Packaging Contents
The film-coated tablets of Daperin 5 mg are yellow, biconvex, round tablets with a diameter of approximately 7.2 mm, film-coated, with "5" engraved on one side and flat on the other.
The film-coated tablets of Daperin 10 mg are yellow, biconvex, oval tablets with dimensions of approximately 11.1 mm x 6.1 mm, film-coated, with "10" engraved on one side and flat on the other.
Daperin tablets are available in OPA/Al/PVC//Al blisters in pack sizes of 10, 28, 30, 60, 90, or 98 film-coated tablets in non-perforated blisters; 14, 28, 56, or 98 film-coated tablets in non-perforated calendar blisters, and in packs of 10x1, 28x1, 30x1, 50x1, 90x1, 98x1, or 100x1 film-coated tablets in perforated unit-dose blisters.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
PharmaPath S.A.
28is Oktovriou 1,
Agia Varvara, 123 51,
Greece
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Hungary Daperin 5 mg & 10 mg filmtabletta
Spain Daperin 5 mg film-coated tablets EFG
Daperin 10 mg film-coated tablets EFG
Portugal Daperin
Date of the last revision of thisleaflet: August 2024
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DAPERIN 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.